Published • loading... • Updated
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
Summary by Missoulian
7 Articles
7 Articles
Missoulian+6 Reposted by 6 other sources
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
SEONGNAM, South Korea, Aug. 23, 2026 /PRNewswire/ -- Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly Gateway Labs (LGL) in San Diego, California.
·Missoula, United States
Read Full ArticleCoverage Details
Total News Sources7
Leaning Left1Leaning Right1Center5Last UpdatedBias Distribution72% Center
Bias Distribution
- 72% of the sources are Center
72% Center
14%
C 72%
14%
Factuality
To view factuality data please Upgrade to Premium
